10-Q Filing

MOLINA HEALTHCARE, INC. CIK: 1179929 Q1 2020

Filing Information

Form Type	10-Q
Accession Number	`0001179929-20-000070`
Period End Date	20200331
Filing Date	20200501
Fiscal Year	2020
Fiscal Period	Q1
XBRL Instance	moh-3312020x10q_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 73 Income Statement 42 Cash Flow Statement 68 Stockholders Equity 21 Comprehensive Income 10

Balance Sheet 73 line items

Line Item	Tag	Value	Unit	Period
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value (usd per share)	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	150.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	59.00M	shares	Point-in-time
Common stock, shares outstanding (in shares)	`CommonStockSharesOutstanding`	62.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.37B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.22B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.45B	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$1.95B	USD	Point-in-time
Preferred stock, par value (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Investments	`MarketableSecuritiesCurrent`	$2.01B	USD	Point-in-time
Preferred stock, par value (usd per share)	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.41B	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	20.00M	shares	Point-in-time
Receivables	`ReceivablesNetCurrent`	$1.60B	USD	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$346.00M	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Prepaid expenses and other current assets	`PrepaidExpenseAndOtherAssetsCurrent`	$163.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$6.32B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$5.97B	USD	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding (in shares)	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$385.00M	USD	Point-in-time
Property, equipment, and capitalized software, net	`PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization`	$385.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$172.00M	USD	Point-in-time
Goodwill and intangible assets, net	`IntangibleAssetsNetIncludingGoodwill`	$168.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$79.00M	USD	Point-in-time
Restricted investments	`RestrictedInvestmentsNoncurrent`	$82.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$71.00M	USD	Point-in-time
Deferred income taxes	`DeferredIncomeTaxAssetsNet`	$79.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$105.00M	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$99.00M	USD	Point-in-time
Total assets	`Assets`	$7.13B	USD	Point-in-time
Total assets	`Assets`	$6.79B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$2.00B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.85B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.98B	USD	Point-in-time
Medical claims and benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$1.96B	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$777.00M	USD	Point-in-time
Amounts due government agencies	`MedicalPremiumLiabilityDueToAgency`	$664.00M	USD	Point-in-time
Accounts payable, accrued liabilities and other	`AccountsPayableAndAccruedLiabilitiesCurrent`	$743.00M	USD	Point-in-time
Accounts payable, accrued liabilities and other	`AccountsPayableAndAccruedLiabilitiesCurrent`	$484.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$43.00M	USD	Point-in-time
Deferred revenue	`ContractWithCustomerLiabilityCurrent`	$249.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$26.00M	USD	Point-in-time
Current portion of long-term debt	`LongTermDebtAndCapitalLeaseObligationsCurrent`	$18.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.57B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$3.27B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.60B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$1.24B	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$229.00M	USD	Point-in-time
Finance lease liabilities	`FinanceLeaseLiabilityNoncurrent`	$231.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$90.00M	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$87.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.48B	USD	Point-in-time
Total liabilities	`Liabilities`	$4.83B	USD	Point-in-time
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 59 million shares at March 31, 2020, and 62 million shares at December 31, 2019	`CommonStockValueOutstanding`	-	USD	Point-in-time
Common stock, $0.001 par value, 150 million shares authorized; outstanding: 59 million shares at March 31, 2020, and 62 million shares at December 31, 2019	`CommonStockValueOutstanding`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $0.001 par value; 20 million shares authorized, no shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$175.00M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$140.00M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$4.00M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-15.00M	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.52B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$1.78B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.65B	USD	Point-in-time
Total stockholders equity	`StockholdersEquity`	$1.96B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$6.79B	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$7.13B	USD	Point-in-time

Income Statement 42 line items

Line Item	Tag	Value	Unit	Period
Premium revenue	`PremiumsEarnedNet`	$3.95B	USD	1 Quarter
Premium revenue	`PremiumsEarnedNet`	$4.30B	USD	1 Quarter
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$150.00M	USD	1 Quarter
Premium tax revenue	`HealthCareOrganizationPremiumTaxRevenue`	$138.00M	USD	1 Quarter
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	$66.00M	USD	1 Quarter
Health insurer fees reimbursed	`HealthCareOrganizationInsurerFeeRevenue`	-	USD	1 Quarter
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$29.00M	USD	1 Quarter
Investment income and other revenue	`InterestAndDividendIncomeOperating`	$29.00M	USD	1 Quarter
Total revenue	`Revenues`	$4.12B	USD	1 Quarter
Total revenue	`Revenues`	$4.55B	USD	1 Quarter
Medical care costs	`CostOfGoodsAndServicesSold`	$3.72B	USD	1 Quarter
Medical care costs	`CostOfGoodsAndServicesSold`	$3.37B	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$302.00M	USD	1 Quarter
General and administrative expenses	`GeneralAndAdministrativeExpense`	$317.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$138.00M	USD	1 Quarter
Premium tax expenses	`PremiumTaxExpenses`	$150.00M	USD	1 Quarter
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	$68.00M	USD	1 Quarter
Health insurer fees	`HealthCareOrganizationInsurerFeeExpense`	-	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$25.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortization`	$20.00M	USD	1 Quarter
Other	`OtherCostAndExpenseOperating`	$3.00M	USD	1 Quarter
Other	`OtherCostAndExpenseOperating`	$4.00M	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$4.28B	USD	1 Quarter
Total operating expenses	`CostsAndExpenses`	$3.84B	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$274.00M	USD	1 Quarter
Operating income	`OperatingIncomeLoss`	$280.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$23.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$21.00M	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	-	USD	1 Quarter
Other income, net	`OtherNonoperatingIncomeExpense`	$3.00M	USD	1 Quarter
Total other expenses, net	`NonoperatingIncomeExpense`	$-20.00M	USD	1 Quarter
Total other expenses, net	`NonoperatingIncomeExpense`	$-21.00M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$260.00M	USD	1 Quarter
Income before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$253.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$75.00M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$62.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$3.19	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$2.95	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.92	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$2.99	USD	1 Quarter

Cash Flow Statement 68 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$20.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationDepletionAndAmortization`	$25.00M	USD	1 Quarter
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-14.00M	USD	1 Quarter
Deferred income taxes	`IncreaseDecreaseInDeferredIncomeTaxes`	$-15.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$12.00M	USD	1 Quarter
Share-based compensation	`ShareBasedCompensation`	$9.00M	USD	1 Quarter
Gain on debt repayment	`GainsLossesOnExtinguishmentOfDebt`	$3.00M	USD	1 Quarter
Gain on debt repayment	`GainsLossesOnExtinguishmentOfDebt`	-	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$6.00M	USD	1 Quarter
Other, net	`OtherOperatingActivitiesCashFlowStatement`	$-3.00M	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$29.00M	USD	1 Quarter
Receivables	`IncreaseDecreaseInReceivables`	$197.00M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$-20.00M	USD	1 Quarter
Prepaid expenses and other current assets	`IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets`	$229.00M	USD	1 Quarter
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$127.00M	USD	1 Quarter
Medical claims and benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$34.00M	USD	1 Quarter
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$113.00M	USD	1 Quarter
Amounts due government agencies	`IncreaseDecreaseInMedicalPremiumLiabilityDueToAgency`	$-35.00M	USD	1 Quarter
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$-30.00M	USD	1 Quarter
Accounts payable, accrued liabilities and other	`IncreaseDecreaseInAccountsPayableAndAccruedLiabilities`	$247.00M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-206.00M	USD	1 Quarter
Deferred revenue	`IncreaseDecreaseInContractWithCustomerLiability`	$-4.00M	USD	1 Quarter
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$60.00M	USD	1 Quarter
Income taxes	`IncreaseDecreaseInAccruedIncomeTaxesPayable`	$43.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$249.00M	USD	1 Quarter
Net cash provided by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$136.00M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$578.00M	USD	1 Quarter
Purchases of investments	`PaymentsToAcquireMarketableSecurities`	$185.00M	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$493.00M	USD	1 Quarter
Proceeds from sales and maturities of investments	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$366.00M	USD	1 Quarter
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$6.00M	USD	1 Quarter
Purchases of property, equipment and capitalized software	`PaymentsToAcquirePropertyPlantAndEquipment`	$21.00M	USD	1 Quarter
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$-3.00M	USD	1 Quarter
Other, net	`PaymentsForProceedsFromOtherInvestingActivities`	$4.00M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$171.00M	USD	1 Quarter
Net cash (used in) provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-103.00M	USD	1 Quarter
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	$453.00M	USD	1 Quarter
Common stock purchases	`PaymentsForRepurchaseOfCommonStock`	-	USD	1 Quarter
Proceeds from borrowings under term loan facility	`ProceedsFromLinesOfCredit`	$380.00M	USD	1 Quarter
Proceeds from borrowings under term loan facility	`ProceedsFromLinesOfCredit`	$100.00M	USD	1 Quarter
Cash paid for partial termination of warrants	`PaymentsForRepurchaseOfWarrants`	$103.00M	USD	1 Quarter
Cash paid for partial termination of warrants	`PaymentsForRepurchaseOfWarrants`	$30.00M	USD	1 Quarter
Cash paid for partial settlement of conversion option	`CashPaidForSettlementOfConversionOption`	$27.00M	USD	1 Quarter
Cash paid for partial settlement of conversion option	`CashPaidForSettlementOfConversionOption`	$115.00M	USD	1 Quarter
Cash received for partial settlement of call option	`ProceedsFromConvertibleDebt`	$27.00M	USD	1 Quarter
Cash received for partial settlement of call option	`ProceedsFromConvertibleDebt`	$115.00M	USD	1 Quarter
Repayment of principal amount of convertible senior notes	`RepaymentsOfConvertibleDebt`	$12.00M	USD	1 Quarter
Repayment of principal amount of convertible senior notes	`RepaymentsOfConvertibleDebt`	$46.00M	USD	1 Quarter
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$-3.00M	USD	1 Quarter
Other, net	`ProceedsFromPaymentsForOtherFinancingActivities`	$1.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-48.00M	USD	1 Quarter
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-118.00M	USD	1 Quarter
Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$372.00M	USD	1 Quarter
Net (decrease) increase in cash, cash equivalents, and restricted cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-85.00M	USD	1 Quarter
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.93B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.42B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.30B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.93B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.42B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$2.51B	USD	Point-in-time
Cash, cash equivalents, and restricted cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents`	$3.30B	USD	Point-in-time
Common stock used for share-based compensation	`StockIssued1`	$7.00M	USD	1 Quarter
Common stock used for share-based compensation	`StockIssued1`	$7.00M	USD	1 Quarter
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter
Change in fair value of derivatives, net	`DerivativeGainLossOnDerivativeNet`	-	USD	1 Quarter

Stockholders Equity 21 line items

Line Item	Tag	Value	Unit	Period
Beginning Balance (in shares)	`SharesOutstanding`	62.10M	shares	Point-in-time
Beginning Balance (in shares)	`SharesOutstanding`	61.90M	shares	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.96B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Beginning Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.83B	USD	Point-in-time
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Common stock purchases	`StockRepurchasedDuringPeriodValue`	$446.00M	USD	1 Quarter
Termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-30.00M	USD	1 Quarter
Termination of warrants	`AdjustmentsToAdditionalPaidInCapitalOther`	$-103.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$5.00M	USD	1 Quarter
Other comprehensive income (loss), net	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-19.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$4.00M	USD	1 Quarter
Share-based compensation	`StockIssuedDuringPeriodValueShareBasedCompensation`	$3.00M	USD	1 Quarter
Ending Balance (in shares)	`SharesOutstanding`	62.10M	shares	Point-in-time
Ending Balance (in shares)	`SharesOutstanding`	61.90M	shares	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.65B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.96B	USD	Point-in-time
Ending Balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.83B	USD	Point-in-time

Comprehensive Income 10 line items

Line Item	Tag	Value	Unit	Period
Net income	`NetIncomeLoss`	$178.00M	USD	1 Quarter
Net income	`NetIncomeLoss`	$198.00M	USD	1 Quarter
Unrealized investment (loss) income	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$7.00M	USD	1 Quarter
Unrealized investment (loss) income	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-25.00M	USD	1 Quarter
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-6.00M	USD	1 Quarter
Less: effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$2.00M	USD	1 Quarter
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$5.00M	USD	1 Quarter
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-19.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$159.00M	USD	1 Quarter
Comprehensive income	`ComprehensiveIncomeNetOfTax`	$203.00M	USD	1 Quarter

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.